SCHEMBL14508197

SCHEMBL14508197

CC1(C)c2cc(-c3cc(-c4ccccn4)cc(-c4ccccn4)c3)ccc2-c2ccc(-c3ccc4c(c3)C(C)(C)c3cc(-c5ccc6c(c5)C(C)(C)c5cc(-c7cc(-c8ccccn8)cc(-c8ccccn8)c7)ccc5-6)ccc3-4)cc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 2/20 0.50
▸ KDM4E B2RXH2 5/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ LMNA P02545 3/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CCR1 P32246 2/20 0.41
▸ CCR5 P51681 2/20 0.41
▸ CCR8 P51685 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ METAP1 P53582 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ DOHH Q9BU89 1/20 0.41
▸ P4HTM Q9NXG6 1/20 0.41
▸ CYP2D6 P10635 1/20 0.40
▸ CYP19A1 P11511 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ CYP2A6 P11509 1/20 0.39
▸ CTSD P07339 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14508179 1.00 PDK2 (0.50) PDK2KDM4ENPC1LMNACYP1A2
SCHEMBL14508278 0.98 PDK2 (0.49) PDK2KDM4ENPC1LMNACYP1A2
SCHEMBL14508262 0.98 PDK2 (0.49) PDK2KDM4ENPC1LMNACYP1A2
SCHEMBL14508168 0.95 PDK2 (0.53) PDK2KDM4ENPC1LMNACYP1A2
SCHEMBL14508138 0.95 PDK2 (0.53) PDK2KDM4ENPC1LMNACYP1A2
SCHEMBL14508225 0.92 PDK2 (0.50) PDK2KDM4ENPC1LMNACYP1A2
SCHEMBL14508204 0.92 PDK2 (0.50) PDK2KDM4ENPC1LMNACYP1A2
SCHEMBL14508169 0.92 PDK2 (0.52) PDK2KDM4ENPC1LMNACYP1A2
SCHEMBL13388817 0.92 PDK2 (0.51) PDK2KDM4ENPC1LMNACYP1A2
SCHEMBL13388806 0.92 PDK2 (0.57) PDK2KDM4ENPC1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070122652-A1 Compound and organic electroluminescent device using same CANON KABUSHIKI KAISHA (JP) 2007-05-31 — — US disclosed
US-20070122652-A1 Compound and organic electroluminescent device using same CANON KABUSHIKI KAISHA (JP) 2007-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070122652-A1 Compound and organic electroluminescent device using same OR10J3, LEF1, RPL19 PDK2 3230/4885KDM4E 960/4885NPC1 3790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback